A mouse model for the disease, the Cstb-deficient (Cstb−/−) mouse, presents with many of the clinical features of EPM1, especially myoclonus starting at the age of 1 month and progressive ataxia manifesting around 6 months of age [4]. This evidence concerns the gene CSTB and Ataxia.